Alternatives to Oryon Cell Therapies

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Enzyme-based technology to break down alcohol in the stomach.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Accelerating breakthroughs in prostate cancer diagnosis and treatment.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

Enabling sustainable and scalable manufacturing of complex, high-value biomolecules through enzymatic biomanufacturing.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A leading organization dedicated to curing and treating cystic fibrosis.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

AI-powered precision testing for patient identification in clinics and clinical trials.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

A biotechnology company developing genetic therapies for rare disorders.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Developing gene editing therapies to lower cholesterol.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

AI-powered knowledge discovery for life sciences.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.